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Abstract 
During  embryogenesis,  the  mammalian
heart  develops  from  a  primitive  heart  tube
originating  from  two  bilateral  primary  heart
fields located in the lateral plate mesoderm.
Cells belongings to the pre-cardiac mesoderm
will  differentiate  into  early  cardiac  progeni-
tors, which express early transcription factors
which are also common to the Isl-1 positive
cardiac  progenitor  cells  isolated  from  the
developing  pharyngeal  mesoderm  and  the
foetal  and  post-natal  mice  hearts.  A  second
population of cardiac progenitor cells positive
to  c-Kit  has  been  abundantly  isolated  from
adult hearts. Until now, these two populations
have been considered two different sets of pro-
genitor cells present in the heart in different
stages  of  an  individual  life.  In  the  present
study we collected embryonic, foetal and infant
hearts, and we tested the hypotheses that c-Kit
positive cells, usually isolated from the adult
heart, are also present in the intra-uterine life
and persist in the adult heart after birth, and
that  foetal Isl-1 positive cells are also positive
to  c-Kit.  Using  immunohistochemistry  we
studied the temporal distribution of Isl-1 posi-
tive and c-Kit/CD105 double positive cells, and
by immunofluorescence and confocal analysis
we studied the co-localization of c-Kit and Isl-1
positive cells. The results indicated that car-
diomyocytes and interstitial cells were positive
for  c-Kit  from  the  9th to  the  19h gestational
week,  that  cells  positive  for  both  c-Kit  and
CD105 appeared in the interstitium at the 17h
gestational week and persisted in the postnatal
age, and that the Isl-1 positive cells were a sub-
set of the c-Kit positive population. 
Introduction
The  mechanisms  involved  in  establishing
the early heart and regulating its morphogene-
sis have been widely studied.1 During embryo-
genesis, the atrioventricular (A-V) canal and
the sinu-atrial segment at the venous pole as
well as the conotruncus at the arterial pole are
added to the heart tube during tube looping.2,3
Most of the cells that will differentiate into the
developing  myocardium  are  derived  from  a
population  of  progenitor  cells  located  in  the
pharyngeal mesoderm, termed the secondary
heart field (SHF).4-6
Cells  belongings  to  the  pre-cardiac  meso-
derm will differentiate into early cardiac pro-
genitors which can in turn differentiate into
primitive cardiomyocytes, smooth muscle cells
and endothelial cells.7 Known markers of pre-
cardiac cells of the primary and the secondary
heart  field  are  Nkx2.5  and  GATA-4.4 The
expression of these two transcription factors is
common  to  the  LIM  homeobox  transcription
factor positive (Isl-1+) cardiac progenitor cells
(CPCs) and the developing pharyngeal meso-
derm8 as  well  as  foetal  and  post-natal  mice
hearts.9 This small number of Isl-1+ cells has
been identified as a residue of the migrating
SHF cells and may be considered resident pro-
genitor cells in the myocardium in the post-
natal age.10
With regard to the Isl-1+ cell distribution,
Genead et al.11 described the frequency of Isl-
1+ cells  in  the  early  first  trimester  human
embryonic heart. They did not observe differ-
ences among the outflow tract, atria and right
ventricle, confirming what had been previous-
ly reported for the late first and early second
trimester.12 Clusters of Isl-1+ cells were identi-
fied in the right atrial wall of foetal and new
born  hearts,  whereas  occasional  Isl-1+ cells
have been found in the ventricular regions.13
Isl-1 has been identified as a marker of CPCs
in the adult rat heart,14,15 giving support to the
hypothesis  that  some  cells  from  the  embryo
may also persist into adulthood.16
Most studies concerning the localisation of
CPCs in the developing heart have been per-
formed in mice or chicks. The localisation and
identification of CPCs in the human foetal and
adult heart has been investigated for the first
time  by  Limana  and  colleagues,17 with  their
analysis limited to epicardium and CD34+ or c-
Kit+ cells. Cells expressing c-Kit were identi-
fied also in the human foetal and post-natal
myocardium  specimens.  These  cells  were
located within the connective tissue and with-
in muscle bundles. Their number declined over
time until the first post-natal month.18
The transmembrane receptor tyrosine kinase
c-Kit is expressed on the cell surface of stem
cells during haematopoiesis,19 dental pulp stem
cells originating from the neural crest cells,20 in
the developing pancreas,21 and recently as been
proposed as a useful marker to differentiate pri-
mary  melanoma  from  compound  nevi.22 Apart
from the many studies on the expression and
localization of this receptor, c-Kit has been pro-
posed  also  as  the  most  important  marker  for
adult CPCs.23,24 The first isolation and character-
isation  of  adult  human  CPCs  has  been  per-
formed  from  percutaneous  right  ventricular
endocardial biopsy specimens by Smith and col-
leagues.25 Multipotent CPCs from human car-
diospheres  consistently  expressed  c-Kit  and
CD105, the regulatory component of the trans-
forming growth factor-breceptor complex that is
important  in  angiogenesis26 and  haemato  -
poiesis.27Therefore, it seems that c-Kit+cells are
CPCs homing the myocardium in the adulthood,
while Isl-1+ cells have been proposed as a differ-
ent subset of undifferentiated cells able to gen-
erate endothelial cells, cardiomyocytes, smooth
muscle cells and cardiac fibroblasts but present
only in the developing heart and persisting in
the post-natal age.8,28,29 In the mean time anoth-
er subset of cardiac undifferentiated cells (epi-
cardial progenitors) has been identified which
barely participate in atria, right ventricle and
outflow tract formation and that are detectable
in the murine and human foetal, but not adult
hearts.30 In  the  present  study,  we  analysed
human  hearts  from  embryos,  foetuses  and
neonates at different gestational ages to deter-
mine the presence and co-localization of the Isl-
1+ CPCs identified in the embryonic and post-
natal heart,  and  the  c-Kit+/CD105+ cells
described in the adultheart, to understand if the
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c-Kit+cells abundantly isolated from adult hearts
are  present  also  in  the  embryonic  and  foetal
heart and if they are a different subset of the
extensively studied Isl-1+ cells. 
Materials and Methods
Human cardiac samples
Cardiac  tissue  samples,  comprising  the
endocardial, myocardial, and epicardial layers
of  the  ventricles,  were  obtained  by  autopsy
from embryos, foetuses, preterm infants, and
term infants and collected, after written con-
sent from the mother, in the Department of
Human Pathology of the University of Messina,
Italy. The procedures followed were in accor-
dance with the ethical standards of the respon-
sible  committee  on  human  experimentation
and with the Helsinki Declaration of 1975. The
Ethics Committee of the University of Messina
approved the study.
Gestational  age  of  the  foetuses  ranged
between 9 and 40 weeks, as shown in Table 1
and Table 2. Specifically, our cohort comprised
25 samples. The causes related to the death of
the analysed foetuses and of the preterm and
term infants are shown in Table 1 and Table 2.
Autopsies and sample collections were carried
out immediately after delivery with less than a
24-hour  interval  since  foetal  death  had
occurred.
All samples were fixed in 10% formalin and
embedded in paraffin for morphological diag-
nostic  evaluation  (haematoxylin/eosin)  and
immunohistochemistry. 
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Table 1. Clinical and morphological data and c-Kit/CD105 expression in 1 embryo, 12 foetuses, 1 preterm infant and 1 term infant.
Case No. Trimester Gestational  Age at  Cause of Heart Cardiomyocytes Endocardium Intestitial 
age (wks) death death malformations cells
Embryo
1I 9 9 wks VT Endocardial cushion  c-Kit+ CD105+ c-Kit+/CD105
defect (AVC of the heart)
Foetuses
2I 13 13 wks SA for chorioamnionitis Absent c-Kit+ CD105+ c-Kit+/CD105-
3 II 14 14 wks TA for CRS VSD c-Kit + CD105+ c-Kit+/CD105-
4 II 14 14 wks SA for chorioamnionitis Absent c-Kit+ CD105+ c-Kit+/CD105-
5 II 14 14 wks TA for cerebral malformations Absent c-Kit+ CD105+ c-Kit+/CD105-
6 II 15 15 wks SA for chorioamnionitis Absent c-Kit+ CD105+ c-Kit+/CD105-
7 II 16 16 wks SA for abruption placentae Absent c-Kit+ CD105+ c-Kit+/CD105-
8 II 17 17 wks TA for cerebral malformations Absent c-Kit+/- CD105+ c-Kit+/CD105+
9 II 18 18 wks TA for MCA Absent c-Kit+/- CD105+ c-Kit+/ CD105+
10 II 19 19 wks TA for PKD, UBH, CLGP left, PEV bilateral Absent c-Ki+/- CD105+ c-Kit +/CD105+
11 II 22 22 wks SA for chorioamnionitis Absent c-Kit+/- CD105+ c-Kit +/CD105+
12 II 22 22 wks SA for chorioamnionitis Absent c-Kit - CD105+ c-Kit +/CD105+
13 III 27 27 wks SA for abruption placentae Absent c-Kit - CD105+ c-Kit +/CD105+
Preterm infant
14 III 36 1 day Respiratory failure Absent c-Kit - CD105+ c-Kit +/CD105+
Term infant
15 III 40 6 yrs Disseminate intravascular coagulation Absent c-Kit - CD105+ c-Kit +/CD105+
TA, therapeutic abortion; SA, spontaneous abortion; CLGP, cheilo-gnatho-palatischisis; CRS, caudal regression syndrome; MCA, multiple congenital anomalies; PEV, pes equino varus; PDK, polycystic kidney disease. 
Table 2. Clinical and morphological data and number of Isl-1 positive cells per area (mm2) in 7 foetuses, 2 preterm infants and 1 term Infant. 
Case No. Trimester Gestational  Age at  Cause of Growth Heart  Section area  Isl-1+ cells/mm2 x 
age (wks) death death defects malformations (mm2) 104*
Foetuses
16 II 14 14 wks Abruptio placentae Absent Absent 56171.5±11561.46 4.523±1.22
17 II 15 15 wks TA for Prune-Belly  Absent Absent 46063±3055.72 3.543±0.15
syndrome
18 II 16 16 wks TA for trisomy 21 IUGR Absent 83666.33±2011.76 1.394±0.17
19 II 19 19 wks TA for trisomy 21 Absent Absent 71642.66±4190.29 1.141±0.62
20 II 20 20 wks TA for trisomy 21 Absent Absent 186604.66±9018 0.735±0.10
21 II 21 21 wks TA for trisomy 21 Absent Absent 119550.33±4100.16 0.889±0.14
22 II 22 22 wks TA for cerebral Absent Absent 162438±7750.21 0.738±0.02
malformations
Preterm infants
23 III 26 8 days Respiratory failure IUGR Ventricular septal  101629±1409.49 1.279±0.08
hypertrophy
24 III 36 2 hrs Sepsis Absent Ventricular septal  165575.33±2524.22 0.664±0.05
hypertrophy
Term infants
25 III 40 8 hrs Respiratory failure Absent Absent 202609±13666.33 0.548±0.12
*Data for which a t-test for dependent samples was performed, P<0.05. Gestational weeks (independent variable); Isl-1+ cells/mm2 (dependent variable); TA,  therapeutic abortion; IUGR, intrauterin
growth retardation; UBH, urinary bladder hypoplasia; VSD, ventricular septal defect; VT, voluntary termination; +, strongly positive; +/-, weakly positive.[European Journal of Histochemistry 2011; 55:e41] [page 231]
Immunohistochemistry
Single  immunohistochemistry  was  per-
formed  by  a  streptavidin-biotin  complex
method  using  LSAB2  kit  (DAKO  Co.,
Carpinteria,  CA,  USA).  After  deparaffination
and rehydration, the tissue sections were incu-
bated with the protein blocking agent (DAKO)
for 10 min and the primary antibody for 1 h. We
used the anti-Isl-1 antibody (1:200, rabbit poly-
clonal, AB5754, Chemicon Int., Millipore Corp.,
Billerica, MA, USA). The linked primary anti-
body was detected with DAKO LSAB2 strepta-
vidin-peroxidase  system  according  to  manu-
facturer’s  instructions.  3-Amino-9-ethylcar-
bazole  (AEC)  was  used  as  a  chromogen,
whereas hematoxylin was used as a light coun-
terstain.
Double  immunohistochemistry  was  per-
formed by a streptavidin-biotin complex for the
goat polyclonal antibody (CD105) and labelled
using polymer-alkalyne phosphatase (AP) for
the  rabbit  polyclonal  antibody  (c-Kit).  After
deparaffination  and  rehydration  the  tissue
sections were incubated with the Peroxidase
Block  solution  (Vector  Laboratories  Inc.,
Burlingame, CA, USA) for 5 min, washed in
PBS for 5 min, and incubated with the anti-
CD105  goat  polyclonal  antibody  (1:50,  SC-
19793, Santa Cruz Biotechnology Inc., Santa
Cruz, CA) for 30 min. After washing in PBS,
sections were incubated with the biotinylated
anti-goat secondary antibody (1:200, SC-2774,
Santa Cruz Biotechnology Inc.) for 30 min, and
washed again in PBS. For the antibody detec-
tion the streptavidin-HRP complex (LSAB2 kit
DAKO) was used for 10 min. Sections were
then rinsed in PBS with 0.1% Tween 20 (T-
PBS)  for  5  min,  and  incubated  with  3,3’-
Diaminobenzidine (DAB–Vector Laboratories)
as the HRP-substrate.
After the detection of the first antigen, sec-
tions  were  incubated  with  the  Doublestain
Block solution (Vector Laboratories) for 3 min,
washed in T-PBS for 5 min, and incubated with
the anti-c-Kit rabbit polyclonal antibody (1:200,
KAP-TK005, Stressgen Bioreagents, Ann Arbor,
MI, USA) for 30 min. After washing with T-PBS
for  5  min,  sections  were  incubated  with  a
labelled  polymer  –  AP  secondary  antibody
(Vector Laboratories) for 30 min, and washed
again. Fast red (Vector Laboratories) was used
as the AP substrate for 5 min. Sections were
then washed in tap water and counterstained
with hematoxylin for 1 min. DAKO Aqueous
mounting medium was used. Each tissue sec-
tion  was  analysed  by  two  independent
observers  (CS  and  PC)  who  evaluated  the
number  of  positive  cells  in  three  paraffin
embedded sections independently stained.
To analyse the number of Isl-1 positive cells
the area of each section was determined. It
was  taken  a  100%-600dpi  picture  of  each
stained slide using an Epson Perfection 1200
Scanner  connected  to  a  personal  computer.
The section sizes were too big to be measured
with pictures taken at the microscope. Each
picture was then converted to an 8-bit picture,
Brightness  was  adjusted  and  Threshold
applied. On the Threshold pictures the Analyze
particles function  of  the  ImageJ  Software
(released by the NIH, http://rsbweb.nih.gov/ij/)
was  applied  to  measure  the  area  of  the
coloured sections. Data are shown in Table 2.
An example of the area measurement is shown
in Appendix Figure 1.
Immunofluorescence
After  deparaffination  and  rehydration,  tis-
sue sections were blocked with 5% BSA in PBS
for 30 min and incubated with the first primary
antibody overnight, one night for each anti-
body  (1:50,  anti-c-Kit,  KAP-TK005,  Stressgen
Bioreagents;  1:50,  anti-Isl-1,  goat  polyclonal,
SC-23590,  Santa  Cruz  Biotechnology  Inc.).
After  washing  with  PBS,  cells  were  further
incubated with fluorescent secondary antibod-
ies 1 h at room temperature (1:50, TRITC-con-
jugated anti-rabbit secondary antibody, T5268,
Sigma-Aldrich, St. Louis, MO; 1:50 FITC-conju-
gated  donkey  anti-goat  secondary  antibody,
SC-2024,  Santa  Cruz  Biotechnology  Inc.).  In
single  immunofluorescence  experiments
nuclei  were  stained  10  min  with  10  μg/mL
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Figure 1. Identification of interstitial c-Kit+/CD105+ and Isl-1+ cells in human foetal and
infant hearts before (A-D) and after (E-G) the 17th gestational week. A, B, C)  c-Kit (Fast
Red) and CD105 (DAB) double immunostaining in a 16-week foetal heart. E, F)  c-Kit
(Fast Red) and CD105 (DAB) double immunostaining in a preterm infant (36 weeks of
gestation, E) and in a term infant (6-year-old child. F) Black arrows indicate double
stained cells. D) Isl-1 (AEC) single immunostaining in a 14-week foetal heart; red arrows
indicate Isl-1 positive cells. G) Isl-1 (AEC) single immunostaining in a 21-week foetal
heart. Double positive cells appeared deep red; red arrow indicate Isl-1 positive cells.[page 232] [European Journal of Histochemistry 2011; 55:e41]
Hoechst33342  staining  in  PBS  (Invitrogen
Corp., Carlsbad, CA, USA). In confocal experi-
ments nuclei were stained 15 min with 1 μM
Toto-3  staining  in  PBS  (T3604,  Invitrogen
Corp.). To avoid cross-reactions, sections were
incubated  with  goat-anti-Isl-1  first  and  with
rabbit anti-c-Kit after, and with donkey anti-
goat first and goat anti-rabbit after, in four dif-
ferent incubations. 
To avoid autofluorescence of paraffin/forma-
lin embedded sections, the samples were incu-
bated in 0.1% Sudan Black in 70% ethanol for
5 min after nuclei staining.31 For imaging they
were  both  used  a  Zeiss  LSM5  Exciter  Laser
Scanning  Confocal  Microscope  and  a  Leica
CTR5000 fluorescent microscope. During con-
focal microscope observations all parameters
for picture acquisition were kept the same and
automatically saved.
Statistical analysis
Data  are  shown  as  mean  values  and  the
standard  deviation  has  been  calculated.  The
hypothesis that the number of Isl-1+ cells per
mm2 varied with the gestational age was test-
ed  using  a  t-test  of  dependent  samples
(P<0.05). The hypothesis that there was a lin-
ear correlation between the gestational age of
the foetuses and the number of Isl-1+ cells per
mm2 was tested using the Pearson coefficient
(P<0.05).  For  the  statistical  analysis  it  was
used  the  STATISTICA  6.0  software  (StatSoft
Italia srl, Vigonza, Italy). 
Results 
Expression of c-Kit on the mem-
brane of cardiomyocytes of foetal
hearts
To study the localization of c-Kit+ CPCs pre-
viously isolated and characterized in the rat
adult heart by our research group,14 we per-
formed immunohistochemistry and immuno-
fluorescence  experiments  on  heart  samples
from embryonic and foetal human hearts. 
As shown in Table 1 and Figure 1 A-C, many
interstitial and subepicardial cells and all car-
diomyocytes were positive for c-Kit from the 9th
to the 17th week of gestation, and sometimes
also to the 22nd week.
The expression of c-Kit on the surface of
cardiomyocytes of the first and second gesta-
tional trimesters was confirmed by immuno-
fluorescence experiments (Figure 2 A, F). In
the  only  embryonic  sample  (9th gestational
week) some structures similar to the primor-
dial  myocardium  of  the  cardiac  tube  were
clearly positive to c-Kit (Figure 2 B-C). Later
on  during  gestation,  clusters  of  c-Kit+ cells
were present (Figure 2 D).
Immunolocalisation of cardiac pro-
genitor cells
In literature there have been clearly identi-
fied two main populations of cardiac progeni-
tor cells: human cells double positive for c-Kit
and CD105 in adult hearts by Smith et al.,25and
cells positive for Isl-1 by Laugwitz et al.9 in the
developing heart. To localize separately the two
populations in the human foetal hearts we per-
formed a double immunostaining for c-Kit and
CD105, and a single immunostaining for Isl-1.
Results  were  summarised  in  Table  1  for  c-
Kit/CD105 and Table 2 for Isl-1.  
Interstitial c-Kit+/CD105+ cells appeared at
the 17th gestational week and persisted after
birth, as shown in Table 1 and Figure 1 E-F.
These double positive cells were localised only
in the myocardium and were never localised
inside  capillaries.  Many  dividing  cells  were
identified  in  the  myocardium  (Figure  1F).
There  were  no  differences  between  normal
hearts and foetuses with heart malformations
(Table 1).
From the 9th to the 16th gestational week,
they were present only c-Kit+ (in the subepi-
cardial space, Figure 1A, and in the myocardi-
um, Figure 1C) or CD105+ cells (endocardium
and endothelium, Figure 1B). Isl-1+ cells were
present in the myocardium and in the suben-
docardium, with no differences between right
and left ventricles. Groups of Isl-1+ cells were
sometimes  visible,  with  a  number  ranging
between 4.523±1.22ﾥ104 at the 14th gestation-
al week and 0.548±0.12ﾥ104 per mm2 in the
post-natal age (Table 2, Figure 1 D,G). The t-
test for dependent variables demonstrated that
the decrease in the number of Isl-1+ cells was
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Figure 2. Expression of c-Kit and Isl-1 in embryonic and foetal hearts. A) Expression of c-
Kit in a 16-week foetal heart. B, C)  Expression of c-Kit in a 9-week human embryo. D)
A cluster of c-Kit+ cells in a 15-week foetal heart. E) Co-localization of c-Kit+ and Isl-1+
cells in a 14-week foetal heart; white arrows indicate cells double positive for Isl-1 and c-
Kit. F) Confocal microscopy analysis of the expression of c-Kit and Isl-1 in the myocardi-
um of a 16-week foetal heart.[European Journal of Histochemistry 2011; 55:e41] [page 233]
significant and that this difference depended
on the gestational week. The number of Isl-1+
cells was higher between the 14th and the 16-
19th gestational weeks and it was almost the
same between the 20th gestational week and
the  post-natal  age.  The  Pearson  coefficient
(r=0.5; P=0.14) demonstrated that there was
not a linear correlation between the gestation-
al week and the number of cells per mm2.
Colocalization of c-Kit+/Isl-1+ cells
To  study  whether  these  markers  were
labelling the same or a different cell popula-
tion, we evaluated the co-expression of c-Kit
and Isl-1. We found that all the interstitial and
subendocardial Isl-1+ cells were positive for c-
Kit (Figure 2E), while not all the cells positive
for  c-Kit  were  Isl-1+ (Appendix  Figure  2).
Cardiomyocytes  were  positive  only  for  c-Kit
(Figure 2F). The co-localization of the expres-
sion of c-Kit and Isl-1 on the same cell was con-
firmed  by  confocal  microscopy  (Appendix
Figure 3).
Discussion
In this study we described the localization
and the temporal distribution of c-Kit+/CD105+
and Isl-1+ cells from the embryonic to the post-
natal heart, and we tested the hypothesis if c-
Kit+ cells abundantly isolated from adult hearts
were also present in the embryonic and foetal
heart and if they represented a subset of cells
different from the Isl-1+ cell population.
Cardiac  precursors  can  be  isolated  from
adult and post-natal hearts,9,32 and are charac-
terized by several markers among which c-Kit
both in foetal17 and adult heart,16 Isl-1 in early
cardiogenesis,9,28 and  CD105  in  human
endomyocardial biopsy specimens.25
With regard to these three CPC markers, the
present study shows that Isl-1+ cells are pres-
ent in the human hearts in foetuses, preterm
infants  and  term  infants,  that  their  number
decreases with the gestational week particu-
larly  after  the  16-19th gestational  week,  and
that there is a difference in the temporal dis-
tribution of c-Kit+ cells. These data also show
that cardiomyocytes and some interstitial cells
are c-Kit+from the 9thto the 16th-19thgestation-
al weeks, and that after this time period, only a
few interstitial cells express c-Kit. Interstitial
cells, which express both c-Kit and CD105 on
their surfaces, are present only from the 17th
week to the 6th year of age. The presence of c-
Kit+/CD105+cells in the different stages of ges-
tation does not demonstrate that c-Kit+ cells
are  resident  cardiac  cells.  But  the  fact  that
many structures in the embryonic heart and
foetal cardiomyocytes are positive to c-Kit in
the early weeks of gestation provides evidence
that c-Kit+ cells are present in the heart from
the  early  stages  of  cardiogenesis,  and  their
number decreases during gestation until the
postnatal age.
We also demonstrated that the interstitial
and  subendocardial  Isl-1+ cells  are  positive
also to c-Kit. The co-localization of the two CPC
markers let us suppose that Isl-1+ cells are a
subset of the c-Kit+ CPCs population usually
isolated and identified in the adult heart.
The hypothesis that c-Kit+ human CPCs are
more abundant in the early stages of gestation
and that their number decreases over time is
supported by a recent paper, where the authors
isolated and grown human CPCs from neonate
and infant specimens.33 The c-Kit+ cells that
the authors isolated and expanded were also
positive  to  Isl-1  in  culture  inside  cardios-
pheres,  supporting  our  hypothesis  that  the
postnatal Isl-1+ cells may be a subpopulation of
c-Kit+ human CPCs, which originate from the
embryonic pre-cardiac mesoderm and probably
persist in the adulthood.
In conclusion, we have demonstrated that
foetal cardiomyocytes are positive to c-Kit, and
that foetal Isl-1+ cells are a subset of foetal c-
Kit+ CPCs. A better understanding of the local-
isation and migration of CPCs during cardio-
genesis  may  be  achieved  using  mouse  or
zebrafish transgenic models.
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